Publications by authors named "Monique Dail"

Claim this Profile
V
Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study.
Rakesh Popat, Meral Beksac, Meletios A Dimopoulos, Moshe E Gatt, Francesca Gay, Monique Dail

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine.
Hartmut Döhner, Keith W Pratz, Courtney D DiNardo, Andrew H Wei, Brian A Jonas, Monique Dail

Blood· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.
Marina Y Konopleva, Monique Dail, Naval G Daver, Jacqueline S Garcia, Brian A Jonas

Clin Lymphoma Myeloma Leuk· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial.
Naval G Daver, Monique Dail, Jacqueline S Garcia, Brian A Jonas, Karen W L Yee

Blood· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of stem cell niche-confined R-spondin 3 expression leads to impaired hematopoiesis.
Antonina V Kurtova, Melanie Heinlein, Simon Haas, Lars Velten, Gerrit J P Dijkgraaf, Monique Dail

Blood Adv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple Myeloma.
Fredrik Schjesvold, Bruno Paiva, Vincent Ribrag, Paula Rodriguez-Otero, Jesus F San-Miguel, Monique Dail

Clin Lymphoma Myeloma Leuk· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax Plus Gilteritinib for -Mutated Relapsed/Refractory Acute Myeloid Leukemia.
Naval Daver, Alexander E Perl, Joseph Maly, Mark Levis, Ellen Ritchie, Monique Dail

J Clin Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and Azacitidine.
Daniel A Pollyea, Keith W Pratz, Andrew H Wei, Vinod Pullarkat, Brian A Jonas, Monique Dail

Clin Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia.
Thomas Prebet, Aaron D Goldberg, Joseph G Jurcic, Samer Khaled, Monique Dail

Leuk Lymphoma· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and IDH1/2 Mutations.
Daniel A Pollyea, Courtney D DiNardo, Martha L Arellano, Arnaud Pigneux, Walter Fiedler, Monique Dail

Clin Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid Leukemia.
Marina Konopleva, Michael J Thirman, Keith W Pratz, Jacqueline S Garcia, Christian Recher, Monique Dail

Clin Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine.
Keith W Pratz, Brian A Jonas, Vinod Pullarkat, Christian Recher, Andre C Schuh, Monique Dail

J Clin Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome.
Aaron T Gerds, Bart L Scott, Peter Greenberg, Tara L Lin, Daniel A Pollyea, Monique Dail

Blood Adv· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma.
Luciano J Costa, Faith E Davies, Gregory P Monohan, Tibor Kovacsovics, Nicholas Burwick, Monique Dail

Blood Adv· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoupling Lineage-Associated Genes in Acute Myeloid Leukemia Reveals Inflammatory and Metabolic Signatures Associated With Outcomes.
Hussein A Abbas, Vakul Mohanty, Ruiping Wang, Yuefan Huang, Shaoheng Liang, Monique Dail

Front Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models.
Raghuveer Singh Mali, Qi Zhang, Rosa Anna DeFilippis, Antonio Cavazos, Vinitha Mary Kuruvilla, Monique Dail

Haematologica· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia.
Anica M Wandler, Benjamin J Huang, Jeffrey W Craig, Kathryn Hayes, Hannah Yan, Monique Dail

Leukemia· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models.
Lina Han, Qi Zhang, Monique Dail, Ce Shi, Antonio Cavazos

Haematologica· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convergent genetic aberrations in murine and human T lineage acute lymphoblastic leukemias.
Benjamin J Huang, Anica M Wandler, Lauren K Meyer, Monique Dail, Anneleen Daemen

PLoS Genet· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia.
Monique Dail, Jason Wong, Jessica Lawrence, Daniel O'Connor, Joy Nakitandwe

Nature· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesis.
Catherine Hartzell, Olga Ksionda, Ed Lemmens, Kristen Coakley, Ming Yang, Monique Dail

Sci Signal· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents.
Monique Dail, Qing Li, Andrew McDaniel, Jason Wong, Keiko Akagi

Proc Natl Acad Sci U S A· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic Kras initiates leukemia in hematopoietic stem cells.
Amit J Sabnis, Laurene S Cheung, Monique Dail, Hio Chung Kang, Marianne Santaguida

PLoS Biol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eph receptors inactivate R-Ras through different mechanisms to achieve cell repulsion.
Monique Dail, Melanie Richter, Pierre Godement, Elena B Pasquale

J Cell Sci· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity.
Mitchell Koolpe, Rosemary Burgess, Monique Dail, Elena B Pasquale

J Biol Chem· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis